These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15757803)

  • 1. Molecular mechanisms in hepatocellular carcinoma development.
    Cha C; Dematteo RP
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):25-37. PubMed ID: 15757803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M; Chawla YK; Kaur J
    Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular therapy and prevention of hepatocellular carcinoma.
    Blum HE
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE
    Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mechanisms of hepatocarcinogenesis.
    Feitelson MA; Sun B; Satiroglu Tufan NL; Liu J; Pan J; Lian Z
    Oncogene; 2002 Apr; 21(16):2593-604. PubMed ID: 11971194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
    Lin YW; Yan MD; Shih YL; Hsieh CB
    Eur J Cancer; 2009 Jul; 45(11):2041-9. PubMed ID: 19410446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH; Moran DM; Jin X; Koniaris LG
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
    Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
    Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
    Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
    Feitelson MA
    Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.